Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000932352-20-000002
Filing Date
2020-11-20
Accepted
2020-11-20 13:08:03
Documents
1
Effectiveness Date
2020-11-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7392
  Complete submission text file 0000932352-20-000002.txt   8702
Mailing Address 305 E. HIGH ST. UNIT 7 BOUND BROOK NJ 08805
Business Address 305 E. HIGH ST. UNIT 7 BOUND BROOK NJ 08805 732-369-5911
Urigen Pharmaceuticals, Inc. (Filer) CIK: 0000932352 (see all company filings)

EIN.: 943156660 | State of Incorp.: DE | Fiscal Year End: 0630
Type: D | Act: 33 | File No.: 021-381138 | Film No.: 201331746
SIC: 2834 Pharmaceutical Preparations